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Cyclin, also known as PCNA or the auxiliary protein of mammalian DNA polymerase 6, is a stable cell 
cycle regulated (synthesized mainly in S-phase) nuclear protein of apparent IU, 36 000 whose rate of synthe- 
sis correlates directly with the proliferative state of normal cultured cells and tissues. Cyclin (PCNA) is ab- 
sent or present in very low amounts in normal non-dividing cells and tissues, but it is synthesized in variable 
amounts by proliferating cells of both normal and transformed origin. All available information indicates 
that this ubiquitous and tightly regulated DNA replication protein is a central component of the pathway(s) 
leading to DNA replication and cell division. 
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1. INTRODUCTION 
The cell cycle of eukaryotic cells is divided into 
periods based on two landmarks, cell division at 
mitosis (M) and replicative DNA synthesis in S- 
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liferating cell nuclear antigen. Note: Cyclin (PCNA) is 
different from the cyclin protein described by Hunt et al. 
in sea urchin eggs [(1983) Cell 33, 389-396) 
phase. The gaps separating mitosis from S-phase 
and the latter from mitosis have been termed G1 
and Gz, respectively ([l] and references therein; 
fig.1). Normal, non-dividing cells are found in a 
resting stage (GO; [l] and references therein) and 
can be stimulated to enter the cell cycle by the ac- 
tion of, external signal molecules such as polypep- 
tide growth factors, hormones and pharmacolog- 
ical agents ([2] and references therein). Alone, or 
in combination, these mitogenic agents trigger an 
orderly sequence of events that culminate in re- 
plicative DNA synthesis and ultimately in cell divi- 
sion. Control mechanisms involved in the choice of 
daughter cells to either cycle or become quiescent 
are thought to operate mainly in GI as resting cells 
have a GI content of DNA ([l] and references 
therein). At present, little is known concerning the 
identity of cellular protein(s) that may be com- 
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Fig. 1. Synthesis and sequence of cyclin (PCNA) antigen distribution during the cell cycle of transformed human amnion 
cells (AMA). (A) Duration of the cell cycle phases. (B) Synthesis of cyclin (PCNA) at various stages of the cell cycle. 
Protein IEF 52 corresponds to a tropomyosin [5,67]. Only the pertinent region of the gel is shown. (C) Sequence of 
cyclin (PCNA) antigen distribution as deduced by indirect immunofluorescence using PCNA autoantibodies specific for 
cyclin. Patterns of cyclin (PCNA) antigen distribution are now known to represent actual patterns of DNA replication 
[47,48,54]. Mitotic, Gr and GZ cells contain cyclin (PCNA) [8] but this form is not recognized by the autoantibodies 
in methanol fixed cells. Cyclin (PCNA) is a stable protein [30]. Modified from Celis and Celis [46,47]. 
ponents of the pathway(s) that control progression 
from Gr to S. The rate of synthesis of these pro- 
teins however is expected to increase substantially 
near the Gr/S transition border of the cell cycle. 
2. CYCLIN (PCNA, AUXILIARY PROTEIN OF 
DNA’POLYMERASE 6): A TIGHTLY 
REGULATED CELL CYCLE PROTEIN 
WITH A ROLE IN CHROMOSOMAL DNA 
REPLICATION 
Studies by Bravo and Celis [3] using high- 
resolution two-dimensional gel electrophoresis 
were amongst the first to search for cell cycle phase 
specific proteins in mammalian cells, Their studies, 
which analyzed global patterns of gene expression 
throughout the cell cycle of HeLa cells identified 
an acidic nuclear protein of apparent M, 36000 
(IEF 49 in the HeLa protein catalogue [4]), later 
termed cyclin [5,6], that was preferentially syn- 
thesized during S-phase ([3,7-lo]; see also fig.1). 
The rate of synthesis of this nuclear protein [I l] 
has been shown to correlate directly with the pro- 
liferative state of normal cultured cells and tissues 
of various species. Cyclin (PCNA) is absent or pre- 
sent in very low amounts in normal non-dividing 
cultured cells (fig.2A) and tissues, but it is syn- 
thesized in variable amounts by proliferating cells 
of both normal and transformed origin ([3-341; see 
also fig.2B). Cyclin (PCNA) synthesis seems to be 
regulated at the level of transcription as suggested 
by in vitro translation experiments [34] and dot 
hybridization studies using the cloned gene [35]. 
Independently, Tan and co-workers [36-441 
characterized autoantibodies found in the sera 
from a small percentage of patients with systemic 
lupus erythematosus (SLE). These autoantibodies 
were shown to stain the nucleus of proliferating 
cells and to react with an acidic polypeptide of M, 
36000 [39,41-431 that was termed proliferating cell 
nuclear antigen (PCNA). In 1984, Mathews and 
colleagues [26] showed that cyclin and PCNA were 
identical. 
Immunofluorescence studies using PCNA au- 
toantibodies specific for cyclin showed that only S- 
phase cells reacted with these antibodies [8,10,23, 
30,34,36,37,39-531 (fig.l), and that various pat- 
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Fig.2. Cyclin (PCNA) synthesis in (A) quiescent (96 h in DMEM containing 0.5% sera) and (B) SV40 transformed 
human MRC-5 fibroblasts. Protein IEF 52 corresponds to a tropomyosin [5,67]. 
terns of cyclin (PCNA) antigen distribution sub- 
divided S-phase [8,10,30,34,46-49,5 l-541 (fig. 1). 
Moreover, many of the cyclin (PCNA) patterns 
were shown to mimic topographical patterns of 
DNA synthesis [8,10,34,47,48,51,52,54] (fig. 3A). 
In particular, late patterns of nucleolar DNA 
replication as determined by [3H]thymidine auto- 
radiography (fig.3Ba) could be superimposed with 
immunofluorescence patterns of cyclin (PCNA) 
antigen distribution ([8,10,34,46,48]; fig.3Bb). 
These, as well as other observations ([ 16,17,22,49] 
and references therein) argued strongly for a role 
of this protein in chromosomal DNA replication. 
A role for cyclin (PCNA) in nucleotide excision 
DNA repair has also been proposed [53]. 
Recently, immunofluorescence and biochemical 
data have firmly established a role for cyclin 
(PCNA) in DNA replication. First, Nakamura and 
colleagues [54] have shown a complete colocaliza- 
tion of cyclin (PCNA) antigen and DNA poly- 
merase cr with replicating replicon clusters as 
visualized with BrdUrd antibodies, and second, 
work by two laboratories identified cyclin (PCNA) 
as the auxiliary protein of mammalian DNA 
polymerase 6 [9,55-571. Cyclin (PCNA) has no 
detectable DNA polymerase, primase, ATPase or 
nuclease activity, but it is able to stimulate the ac- 
tivity of the DNA polymerase 6 core enzyme up to 
a few hundred-fold when using templates with low 
template/primer ratios [55]. Cyclin (PCNA) has 
no effect on the activity of calf thymus DNA 
polymerase a when using similar template/primers 
having long stretches of single-stranded DNA [55]. 
Recent studies by Prelich et al. [56] have further 
shown that cyclin (PCNA) may function in the 
elongation stage of SV40 DNA replication in vitro. 
Cyclin (PCNA) synthesis is activated by the adeno- 
virus ElA gene concomitant with induction of 
cellular. DNA replication [58]. 
Interestingly, many of the properties of cyclin 
(PCNA) resemble those of the P-subunit of E. coli 
DNA polymerase III holoenzyme ([59,60] and 
references therein). Both proteins are required to 
replicate templates with low template/primer 
ratios and exist as dimers of identical subunits. 
These observations as well as the fact that cyclin 
(PCNA) is found at the sites of DNA replication 
throughout S-phase [47,48,54] argue strongly for a 
role of this protein in chromosomal DNA replica- 
tion. A role for DNA polymerase 6 [55,61-641 in 
replicative DNA synthesis is also evident [55,57], 
implying that DNA polymerase cy is not the sole 
polymerase involved in eukaryotic DNA replica- 
tion. Analysis of the rate of synthesis of core 
polymerase 6 throughout the cell cycle should 
reveal if this protein is regulated in a similar 
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PATTERNS OF DNA SYNTHESIS 
Sb SC Se 
B. NUCLEOLAR REPLICATION AND CYCLINtPCNA) DISTRIBUTION 
Sh 
r’ig.3. (A) Topographical patterns of DNA synthesis. African green monkey kidney BS-C-l cells were labelled for 3 h 
with 4&i/ml of [methyl-3H]thymidine. Autoradiograms were exposed for 24 h. Nucleolar replication is seen in Se and 
Sf 1481. Similar results have been observed in AMA cells [47], but the autoradiographic patterns are clearer in BS-C-I 
cells as these exhibit a very flat morphology. (B) Autoradiography (a, [methyl-3H]thymidine incorporation) and 
immunofluorescence (b, PCNA autoantibodies) of BS-C-l cells depicting pattern Sh (see also fig. 1). From Madsen and 
Celis [48]. 
fashion as cyclin (PCNA). Nevertheless, a re- 
evaluation of the polymerases involved in 
eukaryotic DNA replication seems necessary in 
view of the above observations. 
3. CYCLIN (PCNA) IS A CENTRAL 
COMPONENT OF THE PATHWAY(S) 
LEADING TO DNA REPLICATION AND 
CELL DIVISION 
Analysis of proliferating cultured cells from 
various species using two-dimensional gel elec- 
trophoresis, immunofluorescence with PCNA 
(cyclin) autoantibodies, or both, have shown that 
cyclin (PCNA) is a ubiquitous protein. Cyclin 
(PCNA) has so far been detected in proliferating 
cultured cells (S-phase cells) from the following 
vertebrate species: aves, bat, bovine, dog, dolphin, 
goat, hamster, human (fig.2B), mink, monkey, 
mouse, Pisces, potoroo, rabbit and rat ([22,23,25, 
29,451 and references therein). Two variant forms 
of cyclin (PCNA) have been observed: one more 
acidic variant present in human, hamster, potoroo 
and rat, and the other more basic present in mouse 
([13,22] and references therein). The mouse pro- 
tein corresponds to IEF 5 If in the mouse protein 
catalogue [65]. Normal proliferating human cul- 
tured cells that have been shown to synthesize 
cyclin (PCNA) include epidermal basal keratino- 
cytes [19,20], some epithelial amniotic fluid cells 
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([15]; Celis, J.E. and Bravo, R., unpublished 
observations), various types of fibroblasts 
([15,16]; Celis, J.E., unpublished observations) 
and lymphocytes stimulated with phytohemag- 
glutinin (Celis, J.E., unpublished observations; see 
also [37]). Cyclin (PCNA) synthesis declines or 
ceases as cell division and DNA synthesis stop [ 161. 
Interestingly, proliferating repair deficient Xero- 
derma pigmentosum cells (XPSLO, group A; 
XP126L0, group F; XPITE, group C) synthesize 
normal levels of cyclin (PCNA) suggesting that the 
defect(s) is (are) unrelated to this protein, (Celis, 
J.E., unpublished observations). 
As mentioned above, normal non-proliferating 
cultured cells and tissues synthesize very low levels 
of cyclin (PCNA) (fig.2A). Addition of serum or 
platelet-derived growth factor (PDGF) to quies- 
cent 3T3 cells has been shown to result in an in- 
creased synthesis of cyclin (PCNA) late in the 
mitogenic response, just about the time at which 
DNA synthesis begins [17,18,31]. Similar results 
have been observed in quiescent MRC-5 human 
fibroblasts [33] and goat sinovial cells stimulated 
with 20% fetal calf sera (Celis, J.E., unpublished 
observations). Fig. 4A-C shows indirect immuno- 
fluorescence micrographs of quiescent (fig.4A; 96 
h in DMEM containing 0.5% sera) and serum- 
stimulated human MRC-5 fibroblasts [fixed 18 
(fig.4B) and 22 h (fig.4C) after release, S-phase] 
reacted with PCNA autoantibodies specific for 
cyclin. Recently, Sabath et al. [32] identified a pro- 
tein of A4, 36 000 (most likely cyclin (PCNA)) that 
was synthesized at high rates during late Gr and the 
Gr to S-phase transition in T-helper line L2 
stimulated with recombinant human interleukin 2 
(rIL-2). Synthesis of this protein tias inhibited by 
the potassium channel blocker quinine. So far, 
DNA replication in vivo has never been observed 
in the absence of cyclin (PCNA) synthesis, sug- 
gesting that expression of this protein is an 
obligatory event in the Gr to S transition of the cell 
cycle. Cyclin (PCNA) synthesis however can take 
place in vivo in the presence of DNA synthesis in- 
hibitors [30]. 
Further evidence suggesting that cyclin (PCNA) 
may be a central component of the pathway 
leading to DNA replication and cell division comes 
from the study of adult and newborn human and 
mouse tissues, respectively. Most normal human 
adult tissues analyzed by two-dimensional gel elec- 
Fig.4. Indirect immunofluorescence with PCNA 
autoantibodies of quiescent and serum-stimulated 
human MRC-5 fibroblasts. (A) Quiescent (96 h in 
DMEM containing 0.5% sera). (B) 18 h after serum 
stimulation. (C) 22 h after serum stimulation. Nucleolar 
staining can be clearly seen in some cells in (C). 
trophoresis and silver staining exhibit very low or 
undetectable levels of cyclin (PCNA) (Celis; J.E. et 
al., unpublished observations). Tissues so far 
analyzed include: aorta, bladder, cavum oris, 
cerebellar cortex, cerebral cortex, cornea, ductus 
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deferens, epididymis, fat tissue, heart muscle, 
kidney cortex, kidney medulla, larynx, lung, mam- 
mary gland, medulla oblongata, mesencephalon, 
palate, pharynx, posterior eye polus, prostata, rec- 
tum, skeletal muscle, skin, submaxillary glands, 
thyroid gland, trachea, ureter, uterus, veins and 
vesicula seminalis. The fraction of dividing cells 
present in some of these tissues is too low to be 
detected by silver staining. Many newborn mouse 
tissues (gut, spleen, kidney, liver, lung), on the 
other hand, exhibit high levels of cyclin (PCNA) 
([5,66]; Celis, J.E., unpublished observations), 
suggesting that this protein has a central role in cell 
proliferation in all cell types. 
4. CONCLUDING REMARKS 
Cyclin (PCNA) has emerged as a novel central 
component of the pathway(s) that control cell pro- 
liferation in vertebrates. This ubiquitous and tight- 
ly regulated cell cycle specific protein plays a role 
in chromosomal DNA replication and it is a late 
obligatory .component [2] of the mitogenic re- 
sponse. Further studies using in vitro DNA replica- 
tion systems as well as microinjection of 
synchronized cells may help unraveling the precise 
function of this protein in DNA replication and 
cell cycle progression. These studies may have im- 
portant repercussions in cancer chemotherapy. 
Finally, the recent molecular cloning of cyclin 
(PCNA) [35,68] should greatly facilite studies con- 
cerning regulatory aspects of this protein. 
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